ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,809, issued on July 14, was assigned to Exelixis Inc. (Alameda, Calif.).

"Crystalline forms and salt forms of a kinase inhibitor" was invented by Frenel DeMorin (Long Beach, Calif.), Khalid Shah (Half Moon Bay, Calif.), Sagar Shakya (San Diego), Peter Wong (Brisbane, Calif.), Courtney S. Johnson (West Lafayette, Ind.), Melanie Janelle Bevill (West Lafayette, Ind.) and Stephan D. Parent (West Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to crystalline forms of the free base of the c-Met inhibitor, Compound 1. The invention also relates to crystalline forms of salts of Compound 1. The invention also rela...